Mylan Ends Calif. Drug Price Inflation Claims For $57M

By Sindhu Sundar · February 27, 2012, 7:21 PM EST

Mylan Inc. will pay $57 million to resolve all claims by the state of California and a relator in multidistrict litigation accusing the drugmaker of reporting inflated average wholesale prices of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Citizens for Consume, et al v. Abbott Laboratories,, et al

Case Number

Court

Massachusetts

Nature of Suit

Anti-Trust

Date Filed

December 19, 2001

Recent Articles By Sindhu

February 18, 2019
The $1B Question: Can Puerto Rico Afford Its Bankruptcy Bills?
February 18, 2019
Puerto Rico's Law Firms Find Their Footing After Disaster
February 03, 2019
As Puerto Rico Recovers, Courts Heed Lessons Of Disaster
September 09, 2018
Has BigLaw Recovered From The Financial Crisis?
July 02, 2018
4 High Court Lineups That Might Surprise You
June 29, 2018
Justice Kennedy Leaves Mixed Record On Civil Rights
June 17, 2018
Minority Lawyers On Why They Left BigLaw
April 17, 2018
Dropping Ranks: Lathrop's Rough Patch
April 17, 2018
Dropping Ranks: Andrews Kurth's Pre-Merger Dip
April 17, 2018
Dropping Ranks: Stroock's 'Shrink To Grow' Strategy